What we do
The Slimming Clinic is proud to be the UK’s largest provider of private non-surgical medical weight management solutions, specialising in doctor-led and patient-centred online weight loss programmes for those with overweight or obesity.
Our aim is supporting those with overweight and obesity to with a weight loss diet, exercise and lifestyle behavioural changes alongside the use of pharmacotherapy, to improve their health, well-being and reduce weight-related risk factors.
Our weight loss doctors advise patients on realistic and achievable dietary and lifestyle changes which are reviewed and adjustxed weekly as the patient progresses.
Any prescription medication is also reviewed for toleration and efficacy. Dependent on the treatment programme chosen by the patient, their care will be overseen by a doctor plus the additional multi-disciplinary practitioners.
Our Online Weight Loss Programmes
Our online weight loss programmes offer patients varying levels of support enabling us to treat a wide range of patients based on their clinical need and personal circumstances.
Our online weight loss programmes are designed to be a 3-month minimum length of treatment, allowing the medical team to ensure the patients makes sufficient progress towards achieving a 5% total body weight loss from their starting weight in 12 weeks.
As per NICE guidelines, a medical weight loss intervention is deemed effective if the patient reaches this target in 12 weeks.
At The Slimming Clinic we have the ability to adjust and change the patients’ treatment programme and prescription medication if adequate progress is not achieved on their initial programme.
Who Qualifies For Our Online Weight Loss Programmes?
At The Slimming Clinic, our online weight loss programmes are suitable for patients with a BMI 24.9-26.9, however the addition of prescription medication to the treatment programme is only for clinically suitable patients with a BMI of over 27. We have no upper limit of BMI we can treat.
We will consult with any patient with a qualifying BMI from the age of 18 years upwards. Through the variety of prescription medication we offer, we can treat patients up to the age of 75 years if deemed medically suitable by our medical team.
Prescription Anti-Obesity Weight Loss Medication
In line with NICE Clinical Guideline CG189, our doctors will only prescribe anti-obesity weight loss medication to patients with a BMI greater than 30 or BMI greater than 27 with a medical co-morbidity.
If suitable, one of the following medications can be prescribed:
• Fat-blocking capsules – blocks the absorption of 30% of ingested fat from the diet
• Daily weight loss tablets – help to reduce hunger
• Glucagon-like peptide-1 (GLP-1) daily or weekly weight loss injections – help to increase fullness and reduce hunger
Wegovy
Wegovy (Semaglutide), is a once-a-week injectable weight loss medication that works on the appetite receptors in the brain to reduce feelings of hunger and cravings.
The injection imitates GLP1 – a naturally occurring hormone in your body – which is released after you eat and indicates to your brain that you are full. These medications also work to slow the emptying of your stomach, which leads to feelings of fullness for longer after you have eaten.
Mounjaro
Mounjaro, is a weekly weight loss injection with the active ingredient tirzepatide. Tirzepatide works on two different hormonal receptors: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). You may have heard of GLP-1 from other weight loss injections.
GLP-1 helps to regulate blood sugar levels, which in turn talks to the brain to make you feel less hungry and prevent cravings. It also slows down the emptying of the stomach to keep you feeling fuller for longer.
GIP regulates energy balance in brain and fat cells, enhancing the GLP-1 effect of suppressing your appetite and improving sugar control.
By mimicking the effects of both these naturally occurring hormones, Mounjaro has been shown to have greater weight loss potential than medicines that work on GLP-1 alone.
Within one year of starting treatment, 42.3% of those taking tirzepatide had lost at least 15% of their weight.
Xenical (orlistat)
Xenical weight loss medication reduces the absorption of dietary fat, used as an additional weight loss support for overweight and obese patients.
This is a MHRA licensed medication, approved by NICE for the treatment of obesity.
Weight Loss Tablets
These centrally-acting appetite suppressants are sympathomimetic amines that influence noradrenaline and dopamine neurotransmission within the appetite control centre of the brain (hypothalamus).
These medications target the arcuate nucleus of the hypothalamus leading to stimulation of anorexigenic (appetite reducing) pathways resulting in decreased hunger and increased satiety.
The formulations we prescribe are unlicensed medications and Class C/Schedule 3 Controlled Drugs.
Our doctors and prescribing nurses prescribe these medications to the patient as a ‘Special’ according to the Medicines Act (1968) allowing the supply of tailor-made medicinal products to the named patient that cannot be met by licensed medicinal products.
The prescription of this medication remains under the direct personal responsibility of The Slimming Clinic doctor and prescribing nurses. All patients are made aware of the medication being unlicensed before commencing this medication and it is included throughout our patient literature.
These medications are safe and legal to use under the supervision of registered medical practitioner.
Daily Weight Loss Injections
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Saxenda® is the licensed medication for weight loss containing liraglutide. It received a European marketing authorisation in March 2015 and was made available in the UK in January 2017.
It is licensed as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an overweight or obese BMI.
GLP-1 is a physiological regulator of appetite and glucose metabolism. There are two complimentary mechanisms that lead to the effect of GLP-1 on appetite: indirect effects on fullness and satiety through delayed gastric emptying and distension of the stomach and direct effects on GLP-1 receptors in the appetite control centre of the brain.
Book your online consultation or request yoiur medication directly online today!